SCHEMBL2802343

SCHEMBL2802343

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3ccccc3S(C)(=O)=O)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.38
JAK1 P23458 2/20 0.38
TYK2 P29597 2/20 0.38
LMNA P02545 1/20 0.38
SPR P35270 2/20 0.38
THRA P10827 1/20 0.37
VDR P11473 1/20 0.37
CCKBR P32239 1/20 0.36
SIRT5 Q9NXA8 1/20 0.36
ALDH1A1 P00352 2/20 0.36
JAK3 P52333 1/20 0.36
PTK2 Q05397 1/20 0.36
FASN P49327 1/20 0.36
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
THRB P10828 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MGLL Q99685 1/20 0.35
TPSAB1 Q15661 1/20 0.35
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801510 0.91 EGLN1 (0.38) SPRSIRT5ALDH1A1FASNL3MBTL1
SCHEMBL2803213 0.91 NPC1 (0.40) SPRSIRT5ALDH1A1FASNL3MBTL1
SCHEMBL2800478 0.90 SIRT5 (0.46) SPRCCKBRSIRT5ALDH1A1FASN
SCHEMBL2803776 0.89 SPR (0.38) LMNASPRSIRT5ALDH1A1FASN
SCHEMBL2798787 0.89 TNF (0.36) LMNASPRCCKBRSIRT5ALDH1A1
SCHEMBL2802383 0.88 HPGD (0.45) TYK2ALDH1A1L3MBTL1
SCHEMBL2801637 0.88 SIRT5 (0.41) LMNASPRCCKBRSIRT5ALDH1A1
SCHEMBL2798793 0.88 SPR (0.41) SPRCCKBRSIRT5ALDH1A1FASN
SCHEMBL2802799 0.87 ALDH1A1 (0.40) LMNASPRSIRT5ALDH1A1FASN
SCHEMBL2800861 0.87 TP53 (0.39) SPRALDH1A1FASN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 JAK2 857/4885JAK1 210/4885TYK2 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.